Stapled Peptide Modules for Intracellular Cargo Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Many therapeutic and diagnostic agents struggle to cross cell membranes efficiently, limiting their ability to reach intracellular targets within cells.

Innovation Solution

Development of cell-permeable stapled peptides that are structurally stabilized through internal cross-linking, allowing them to transport various cargoes, including therapeutic agents and diagnostic molecules, into cells by maintaining a constrained structure and enhancing hydrophobicity and protease resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If therapeutic and diagnostic agents are designed to bind with strong affinity to intracellular disease targets, then binding strength is improved, but cell membrane permeability deteriorates

Engineering Contradiction:
Improvebinding strengthVSAvoidcell membrane permeability
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The invention segments the delivery system into two functional components: a cell-permeable carrier peptide and a cargo molecule with disease-target binding activity. The carrier peptide (e.g., stapled peptides like ATSP-7041 or CPSP modules) handles membrane traversal, while the cargo (e.g., stapled BCL-2 family peptides) provides specific target binding. This segmentation allows each component to be optimized for its specific function without compromise.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The cell-permeable carrier peptide acts as an intermediary that ferries the cargo across the cell membrane barrier. The carrier peptide temporarily associates with the cargo, mediates its transport through the membrane, and facilitates intracellular delivery. This intermediary approach resolves the contradiction by decoupling the membrane traversal function from the target binding function.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If peptides are made more hydrophobic to enhance cell membrane permeability, then cell permeability is improved, but protease resistance deteriorates

Engineering Contradiction:
Improvecell membrane permeabilityVSAvoidprotease resistance
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The invention changes the structural parameters of the peptide through stapling modifications, which alter the conformational ensemble and physical properties. Stapled peptides exhibit modified hydrophobicity, increased rigidity, and enhanced protease resistance simultaneously. The cyclic constraint introduced by stapling changes the peptide's parameters in a way that improves multiple properties at once, including membrane permeability and stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates composite peptide structures by combining natural amino acid sequences with non-natural staple modifications. These composite molecules integrate the cell-permeable properties of hydrophobic sequences with the stability provided by the cyclic staple structure. The composite nature allows simultaneous optimization of permeability and protease resistance.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS11952432B2Cell-permeable stapled peptide modules for cellular delivery
Publication Date: 2024.04.09 DANA FARBER CANCER INSTITUTE INC
  • US11952432B2 patent drawing
  • US11952432B2 patent drawing
  • US11952432B2 patent drawing

AI summary

The disclosure relates to cell-permeable stabilized peptide modules and methods of use for e.g., cellular delivery of cargoes.